Meng Xu Welliver MD Ph.D.
Hematologic Malignancies, Sarcoma, Thoracic Cancer
Associate Professor of Radiation Oncology Senior Associate Consultant
Join to view full profile
200 first St SWRadiation OncologyRochester, MN 55905
Phone+1 507-284-3261
Dr. Welliver is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Meng Welliver is a Radiation Oncologist specializing in hematologic malignancies, sarcoma, and thoracic cancer, based in Rochester, MN. She completed her medical education at Pennsylvania State University College of Medicine and trained in Internal Medicine and Radiation Oncology at the University of Pennsylvania Health System. Dr. Welliver is an Associate Professor at Mayo Clinic, having previously held similar roles at OSU and served as an Attending Physician at the Ohio State University Wexner Medical Center. Her clinical expertise includes treating mesothelioma, non-Hodgkin lymphoma, lung cancer, thymoma, and soft tissue sarcomas. She has been involved in multiple clinical trials focused on advanced cancer treatments and has published significant research articles in reputed journals. Dr. Welliver has also received several CMS Meaningful Use certifications from Epic Systems Corporation.
Education & Training
University of Pennsylvania Health SystemResidency, Radiation Oncology, 2007 - 2011- University of Pennsylvania Health SystemInternship, Internal Medicine, 2006 - 2007
Pennsylvania State University College of MedicineClass of 2006
Certifications & Licensure
MN State Medical License 2023 - 2027
OH State Medical License 2011 - 2027
WI State Medical License 2024 - 2027
MS State Medical License 2021 - 2022
PA State Medical License 2006 - 2016
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
Clinical Trials
- Trametinib, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery Start of enrollment: 2013 Oct 28
- Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies Start of enrollment: 2015 Jul 27
- Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Start of enrollment: 2014 Aug 12
Publications & Presentations
PubMed
- 2 citationsStaged Reconstruction Is Not Necessary Following Oncologic Resection of Superficial Myxofibrosarcoma.Leilani Garayua-Cruz, Samuel E Broida, Mikaela H Sullivan, Andrew L Folpe, Meng X Welliver
Cancers. 2025-11-12 - 1 citationsParkin deficiency promotes colorectal tumorigenesis and progression through RIPK3-dependent necroptotic inflammation.Zheming Wu, Huaping Xiao, Jake A Kloeber, Yaobin Ouyang, Ping Yin
Cancer Communications. 2025-04-01 - 3 citationsA Phase 2 Trial of Primary Tumor Stereotactic Body Radiation Therapy Boost Before Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer.Terence M Williams, Eric Miller, Meng Welliver, Jeremy Brownstein, Gregory Otterson
International Journal of Radiation Oncology, Biology, Physics. 2024-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: